Patents by Inventor Darren Jason Mitchell

Darren Jason Mitchell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroquinoline derivatives useful as bromodomain inhibitors
    Patent number: 9029395
    Abstract: Tetrahydroquinoline derivatives, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: May 12, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Dominique Amans, Emmanuel Hubert Demont, Darren Jason Mitchell, Robert J. Watson
  • Tetrahydroquinoline derivatives useful as bromodomain inhibitors
    Patent number: 8993554
    Abstract: Tetrahydroquinoline compounds, pharmaceutical compositions containing such compounds and their use in therapy.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: March 31, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Dominique Amans, Emmanuel Hubert Demont, Darren Jason Mitchell, Jonathan Thomas Seal
  • Compounds
    Patent number: 8853218
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: October 7, 2014
    Assignee: Glaxo Group Limited
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Mervyn Thompson, Susan Marie Westaway, Samantha Louisa Brown
  • Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors
    Publication number: 20140039006
    Abstract: Tetrahydroquinoline derivatives, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: April 19, 2012
    Publication date: February 6, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Dominique Amans, Emmanuel Hubert Demont, Darren Jason Mitchell, Robert J. Watson
  • Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors
    Publication number: 20140031336
    Abstract: Tetrahydroquinoline compounds, pharmaceutical compositions containing such compounds and their use in therapy.
    Type: Application
    Filed: April 19, 2012
    Publication date: January 30, 2014
    Applicant: Glaxosmithkline LLC
    Inventors: Dominique Amans, Emmanuel Hubert Demont, Darren Jason Mitchell, Jonathan Thomas Seal
  • Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases
    Patent number: 7964597
    Abstract: Disclosed are motilin agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: June 21, 2011
    Assignee: Glaxo Group Limited
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Biaryl compounds useful as agonists of the Gpr38 receptor
    Patent number: 7964602
    Abstract: The present invention relates to novel biaryl derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: June 21, 2011
    Assignee: Glaxo Group Limited
    Inventors: Gregor James MacDonald, Darren Jason Mitchell, Mervyn Thompson, Susan Marie Westaway
  • PIPERAZINYL-SULFONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES
    Publication number: 20100256364
    Abstract: Disclosed are motilin agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Application
    Filed: November 26, 2008
    Publication date: October 7, 2010
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • COMPOUNDS
    Publication number: 20090192160
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Application
    Filed: April 2, 2009
    Publication date: July 30, 2009
    Inventors: Darren Jason MITCHELL, Jonathan Thomas Seal, Mervyn Thompson, Susan Marie Westway, Samantha Louisa Brown
  • Vanilloid receptor modulators
    Patent number: 7538121
    Abstract: Certain compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, P, X, Y, q, r ans s are as defined in the specification, a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds in medicine.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: May 26, 2009
    Assignee: Glaxo Group Limited
    Inventors: Gregor James MacDonald, Darren Jason Mitchell, Harshad Kantilal Rami, Mervyn Thompson, Susan Marie Westaway
  • Carboxamide derivatives
    Patent number: 7531558
    Abstract: Compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein P, W, X, Y, R2, R3, r and s are as defined in the specification, processes for preparing such compounds, pharmaceutical compositions comprising such compounds and their use in therapy.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: May 12, 2009
    Assignee: Glaxo Group Limited
    Inventors: Gregor James Macdonald, Darren Jason Mitchell, Harshad Kantilal Rami, Mervyn Thompson, Leontine Saskia Trouw, Susan Marie Westaway
  • Biaryl Compounds Useful as Agonists of the Gpr38 Receptor
    Publication number: 20080306083
    Abstract: The present invention relates to novel biaryl derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: December 1, 2006
    Publication date: December 11, 2008
    Inventors: Gregor James MacDonald, Darren Jason Mitchell, Mervyn Thompson, Susan Marie Westaway